Supernus Pharmaceuticals, Inc. FDA Record
- Latest inspection NAI · Jul 31, 2025
- No warning letters matched by name
Supernus Pharmaceuticals, Inc. has 3 FDA recalls, 6 inspections, 0 510(k) clearances and 0 compliance actions on record. No FDA warning letter addressed to "Supernus Pharmaceuticals, Inc." is on file.
- Latest recall
- D-0833-2026 · Class III · Aug 31, 2026
- Latest inspection
- Jul 31, 2025 · NAI
Summary
| Records | Count | Last refreshed | Source as of | Status |
|---|---|---|---|---|
| Recalls | 3 | Nov 11, 2026 (checked Nov 15, 2026, unchanged) | File dated Nov 10, 2026 | Current |
| 510(k) clearances | 0 | Nov 15, 2026 | File dated Nov 9, 2026 | Current |
| Inspections | 6 | Nov 16, 2026 | Newest record Nov 5, 2026 | Current |
| Compliance actions | 0 | Nov 2, 2026 | Newest record Oct 29, 2026 | Current |
FDA record by year
Supernus Pharmaceuticals, Inc.: FDA inspections per year
| Year | Inspections | OAI | Warning letters | Recall records | Class I |
|---|---|---|---|---|---|
| 2026 | 0 | 0 | 0 | 2 | 0 |
| 2025 | 1 | 0 | 0 | 0 | 0 |
| 2024 | 0 | 0 | 0 | 0 | 0 |
| 2023 | 0 | 0 | 0 | 0 | 0 |
| 2022 | 0 | 0 | 0 | 0 | 0 |
| 2021 | 0 | 0 | 0 | 0 | 0 |
| 2020 | 0 | 0 | 0 | 0 | 0 |
| 2019 | 2 | 0 | 0 | 0 | 0 |
| 2018 | 0 | 0 | 0 | 0 | 0 |
| 2017 | 1 | 0 | 0 | 0 | 0 |
Reviewing Supernus Pharmaceuticals, Inc. as a supplier? Request a free FDA snapshot: name up to five suppliers and get a PDF of their public FDA record, with sources and dates. You do not need an API connection. Each snapshot is prepared by hand.
Or check Supernus Pharmaceuticals, Inc. yourself in Claude, Cursor or ChatGPT: get the full FDA risk summary, with inspections, warning letters, Form 483s and import alerts by site.
Recent recalls
| Number | Class | Product | Date |
|---|---|---|---|
| D-0833-2026 | Class III | Trokendi XR, (topiramate) extended-release capsules, 50 mg, 30 Capsules, Rx only, Manufactured by… | Aug 31, 2026 |
| D-0758-2026 | Class III | Trokendi XR, topiramate extended-release capsules, 25mg, 30 Capsules, Rx only, Manufactured by… | Jul 6, 2026 |
| D-0112-2017 | Class II | Trokendi XR (topiramate) extended-release capsule, 50mg, 30-count blister pack, Rx only… | Jul 12, 2016 |
Recent FDA inspections
| Date | Site | Product | Classification | FEI |
|---|---|---|---|---|
| Jul 31, 2025 | Rockville, MD | Drugs | No Action Indicated (NAI) | 3005209462 |
| Oct 10, 2019 | Rockville, MD | Drugs | No Action Indicated (NAI) | 3005209462 |
| Jul 10, 2019 | Rockville, MD | Drugs | No Action Indicated (NAI) | 3005209462 |
| Feb 3, 2017 | Rockville, MD | Drugs | Voluntary Action Indicated (VAI) | 3005209462 |
| Feb 23, 2015 | Rockville, MD | Drugs | No Action Indicated (NAI) | 3005209462 |
| Jun 19, 2014 | Rockville, MD | Drugs | No Action Indicated (NAI) | 3005209462 |
- NAI
- No objectionable conditions or practices were found during the inspection.
- VAI
- Objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action.
- OAI
- Regulatory and/or administrative actions are recommended.
FDA-inspected facilities
| Facility | Location | Inspections | Latest |
|---|---|---|---|
| FEI 3005209462 | Rockville, MD | 6 | Jul 31, 2025 |
Supernus Pharmaceuticals, Inc. and the FDA: common questions
Has Supernus Pharmaceuticals, Inc. received an FDA warning letter?
No FDA warning letter addressed to the name "Supernus Pharmaceuticals, Inc." is on file. This answer covers that name only: letters addressed to a related company name or to one of its sites are listed on that name's or site's own page.
Has Supernus Pharmaceuticals, Inc. received an FDA Form 483?
FDA has not published a Form 483 for "Supernus Pharmaceuticals, Inc." in its reading room. FDA publishes some Form 483s, not all of them.
When did the FDA last inspect Supernus Pharmaceuticals, Inc.?
The most recent FDA inspection on file ended Jul 31, 2025 at Rockville, MD and was classified NAI. FDA has 6 inspections of Supernus Pharmaceuticals, Inc. on file.
Has Supernus Pharmaceuticals, Inc. had an FDA recall?
Yes. Supernus Pharmaceuticals, Inc. has 3 FDA recalls on record. The most recent started Aug 31, 2026.
Need more than this page shows? Ask about Supernus Pharmaceuticals, Inc. in Claude or ChatGPT and get every site's inspections, Form 483s, warning letters and import alerts, with a link to the FDA source for each record. The API key is free: no card.